Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-08 Graham Juan Chief Financial Officer Sale −2,749 $21.16 $58K 70,213
2023-03-08 Graham Juan Chief Financial Officer Grant or award +2,899 73,112
2023-03-08 Graham Juan Chief Financial Officer Grant or award +4,668 77,780
2023-03-08 Wettig Thane Chief Commercial Officer Sale −6,265 $21.16 $133K 104,090
2023-03-08 Wettig Thane Chief Commercial Officer Grant or award +5,799 109,889
2023-03-08 Wettig Thane Chief Commercial Officer Grant or award +9,338 119,227
2023-03-02 Eisner Mark Chief Medical Officer Sale −1,187 $21.87 $26K 172,496
2023-02-21 Wettig Thane Chief Commercial Officer Grant or award +25,000 110,355
2023-02-21 Wettig Thane Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +42,000 42,000
2023-02-21 Graham Juan Chief Financial Officer Grant or award +25,000 72,962
2023-02-21 Graham Juan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +42,000 42,000
2023-02-21 Chung Christine SVP, China Operations Grant or award +25,000 259,873
2023-02-21 Chung Christine SVP, China Operations Grant or award · Stock Option (Right to Buy) +42,000 42,000
2023-02-21 Eisner Mark Chief Medical Officer Grant or award +32,500 173,683
2023-02-21 Eisner Mark Chief Medical Officer Grant or award · Stock Option (Right to Buy) +55,000 55,000
2023-02-21 Conterno Enrique A Chief Executive Officer Grant or award +85,300 380,783
2023-02-21 Conterno Enrique A Chief Executive Officer Grant or award · Stock Option (Right to Buy) +143,100 143,100
2023-01-06 Conterno Enrique A Chief Executive Officer Sale −1,538 $19.95 $31K 295,483
2022-12-23 Wettig Thane Chief Commercial Officer Sale −734 $15.80 $12K 89,163
2022-12-12 Graham Juan Chief Financial Officer Sale −1,407 $14.50 $20K 47,962

Page 10 of 16 · 320 trades